Rapp Michael A, Schnaider-Beeri Michal, Purohit Dushyant P, Perl Daniel P, Haroutunian Vahram, Sano Mary
Department of Psychiatry, Mount Sinai School of Medicine, New York, USA.
Am J Geriatr Psychiatry. 2008 Feb;16(2):168-74. doi: 10.1097/JGP.0b013e31816029ec.
Recent evidence suggests that a history of major depression may lead to increases in hippocampal neuropathology in Alzheimer disease (AD). The authors tested the hypothesis that neuritic plaques and neurofibrillary tangles are more pronounced in the brains of patients with AD with comorbid depression as compared with patients with AD without depression.
Brain samples from patients were selected from the U.S. National Alzheimer's Coordinating Center database. The primary analysis included 7164 individuals: 6468 had AD as the primary neuropathologic diagnosis and 696 were considered neuropathologically normal. Depression at study inclusion was rated as present or absent in consensus conferences. Neuropathologic ratings from the Consortium to Establish a Registry in Alzheimer's Disease rating of neuritic plaques and Braak staging of neurofibrillary tangles were used for between-group analyses.
Brains of patients with AD with comorbid depression showed higher levels of cortical tangle formation than brains of patients with AD without comorbid depression. Results remained stable when controlling for age, gender, level of education, and cognitive status. Within patients with AD, comorbid depression increased the odds for advanced neuropathologic disease stage (odds ratio: 1.47; 95% confidence interval: 1.03-2.08).
In AD, the presence of depression comorbidity corresponds to increases in AD-related neuropathologic changes beyond age, gender, level of education, and cognitive status, suggesting an interaction between depression and the neuropathologic processes in AD.
近期证据表明,重度抑郁症病史可能导致阿尔茨海默病(AD)患者海马神经病理学改变增加。作者检验了这样一个假设,即与无抑郁症的AD患者相比,合并抑郁症的AD患者大脑中神经炎性斑块和神经原纤维缠结更为明显。
从美国国家阿尔茨海默病协调中心数据库中选取患者的脑样本。主要分析纳入7164人:6468人以AD作为主要神经病理学诊断,696人经神经病理学检查认为正常。在共识会议上,将纳入研究时的抑郁症评定为存在或不存在。采用阿尔茨海默病注册协会神经炎性斑块评分和神经原纤维缠结Braak分期的神经病理学评分进行组间分析。
合并抑郁症的AD患者大脑皮质缠结形成水平高于无合并抑郁症的AD患者。在控制年龄、性别、教育程度和认知状态后,结果保持稳定。在AD患者中,合并抑郁症增加了神经病理学疾病晚期的几率(优势比:1.47;95%置信区间:1.03 - 2.08)。
在AD中,合并抑郁症与超出年龄、性别、教育程度和认知状态的AD相关神经病理学变化增加相关,提示抑郁症与AD神经病理学过程之间存在相互作用。